2Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
3Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia
4Moscow Institute of Physics and Technology, 141700 Dolgoprudny, Moscow Region, Russia
* To whom correspondence should be addressed.
Received: November 20, 2023; Revised: March 27, 2024; Accepted: April 11, 2024
Currently, numerous associations between genetic polymorphisms and various diseases have been characterized through the Genome-Wide Association Studies. Majority of the clinically significant polymorphisms are localized in non-coding regions of the genome. While modern bioinformatic resources make it possible to predict molecular mechanisms that explain influence of the non-coding polymorphisms on gene expression, such hypotheses require experimental verification. This review discusses the methods for elucidating molecular mechanisms underlying dependence of the disease pathogenesis on specific genetic variants within the non-coding sequences. A particular focus is on the methods for identification of transcription factors with binding efficiency dependent on polymorphic variations. Despite remarkable progress in bioinformatic resources enabling prediction of the impact of polymorphisms on the disease pathogenesis, there is still the need for experimental approaches to investigate this issue.
KEY WORDS: functional polymorphisms, regulatory genomic regions, transcription factors, reporter analysis, CRISPR-CasDOI: 10.1134/S0006297924060026
Publisher’s Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.